Modulight Corporation | Company Release | June 05, 2026 at 11:42:00 EEST
Modulight has identified an error in the presentation of certain balance sheet items in the financial statements released on 24-Apr-2026.
The error relates to the presentation of current liabilities. The amounts reported under accrued expenses and total current liabilities were incorrect.
The correct figures are as follows (EUR thousand):
Balance sheet itemPublished figureCorrect figureLiabilities Non-current liabilities Loans from financial institutions988988 Total non-current liabilities988988 Current liabilities Loans from financial institutions1,5021,502 Advances received5353 Accounts payable285285 Other liabilities164164 Accrued expenses1,0851,447 Total current liabilities1,9493,451Total liabilities4,4394,439The correction does not affect the Company's total liabilities, total assets, shareholders' equity, cash flow, operating result, profit for the financial year, or any previously reported key performance indicators. The correction concerns only the presentation of balance sheet items.
The corrected figures have been updated in the financial statements available on the Company's website.
The Company regrets the error.
For further information, please contact:
CEO Seppo Orsila, m. +358 40 830 4671
IR Ulla Haapanen, m. +358 40 830 4676
Email:
Certified adviser: Sisu Partners Oy, m. +358 40 555 4727
modulight.com
@modulight
Modulight in brief
Modulight Corporation is a life science company that designs and manufactures laser devices for the treatment of cancer and eye diseases. The company also manufactures products for other high value-add applications including flow cytometry, microscopy, semiconductor, quantum, and defense. The company’s products include medical devices, subsystems, software, cloud services, and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.
Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #KillCancer